SK8599A3 - Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal - Google Patents
Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal Download PDFInfo
- Publication number
- SK8599A3 SK8599A3 SK85-99A SK8599A SK8599A3 SK 8599 A3 SK8599 A3 SK 8599A3 SK 8599 A SK8599 A SK 8599A SK 8599 A3 SK8599 A3 SK 8599A3
- Authority
- SK
- Slovakia
- Prior art keywords
- carbon atoms
- alkylene
- group
- formula
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
- C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D233/14—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2313996P | 1996-07-30 | 1996-07-30 | |
| US89577297A | 1997-07-17 | 1997-07-17 | |
| PCT/US1997/013422 WO1998004537A1 (en) | 1996-07-30 | 1997-07-30 | Novel compounds and compositions for treating diseases associated with tryptase activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK8599A3 true SK8599A3 (en) | 2000-03-13 |
Family
ID=26696778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK85-99A SK8599A3 (en) | 1996-07-30 | 1997-07-30 | Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0934293A1 (xx) |
| JP (1) | JP2001509787A (xx) |
| KR (1) | KR20000029679A (xx) |
| CN (1) | CN1073103C (xx) |
| AU (1) | AU733621B2 (xx) |
| CA (1) | CA2262542A1 (xx) |
| CZ (1) | CZ29799A3 (xx) |
| EE (1) | EE9900036A (xx) |
| FI (1) | FI990171A (xx) |
| HU (1) | HUP0003267A3 (xx) |
| LV (1) | LV12291B (xx) |
| NO (1) | NO990433L (xx) |
| NZ (1) | NZ333713A (xx) |
| PL (1) | PL331465A1 (xx) |
| SI (1) | SI9720047A (xx) |
| SK (1) | SK8599A3 (xx) |
| WO (1) | WO1998004537A1 (xx) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| EP1060175B1 (de) * | 1998-02-06 | 2004-11-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| WO1999040073A2 (de) * | 1998-02-06 | 1999-08-12 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| EP1115731A2 (de) * | 1998-09-04 | 2001-07-18 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue pyranosen |
| KR20020016942A (ko) | 1999-08-10 | 2002-03-06 | 빅 굴덴 롬베르크 케미쉐 파브릭 게엠베하 | 디아조신-디온 유도체 및 이것의 트립타제 억제제로서 용도 |
| EP1216236A1 (en) * | 1999-09-14 | 2002-06-26 | Byk Gulden Lomberg Chemische Fabrik GmbH | Tryptase inhibitors |
| WO2001036386A1 (fr) * | 1999-11-17 | 2001-05-25 | Sumitomo Pharmaceuticals Co., Ltd. | Traitement du diabete contenant un derive de dipiperazine |
| DE19955476A1 (de) * | 1999-11-18 | 2001-05-23 | Boehringer Ingelheim Pharma | Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| AU783217B2 (en) * | 1999-12-20 | 2005-10-06 | Altana Pharma Ag | Tryptase inhibitors |
| AU783371B2 (en) | 1999-12-20 | 2005-10-20 | Altana Pharma Ag | Tryptase inhibitors |
| ES2225758T3 (es) | 2001-01-31 | 2005-03-16 | Altana Pharma Ag | Derivdos de diazocina y su uso como agentes inhibidores de la triptasa. |
| AU2002253026B2 (en) * | 2001-02-21 | 2007-08-09 | Altana Pharma Ag | Tryptase inhibitors |
| JP2004518736A (ja) | 2001-02-21 | 2004-06-24 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| WO2002074732A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| US20040087792A1 (en) * | 2001-03-15 | 2004-05-06 | Thomas Martin | Tryptase-inhibitors |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| EP2085087A1 (en) | 2001-06-11 | 2009-08-05 | Xenoport, Inc. | Prodrugs of gaba analogs, compositions and uses thereof |
| ATE348803T1 (de) | 2001-06-19 | 2007-01-15 | Altana Pharma Ag | Tryptase-inhibitoren |
| RU2440112C2 (ru) | 2004-11-04 | 2012-01-20 | Ксенопорт, Инк. | Пероральная дозированная форма габапентина замедленного высвобождения |
| AU2009328497A1 (en) | 2008-12-19 | 2010-06-24 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| TWI432188B (zh) | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類 |
| FR3038605B1 (fr) | 2015-07-06 | 2018-08-24 | Universite Amiens Picardie Jules Verne | Diamines primaires vicinales associees a des motifs chelateurs de metaux et/ou de radicaux libres, actives contre les stress carbonyle et oxydant et leur utilisation |
| CN110869362A (zh) * | 2017-05-12 | 2020-03-06 | 国立研究开发法人理化学研究所 | A类gpcr结合性化合物改性体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845242A (en) * | 1987-04-28 | 1989-07-04 | Georgia Tech Research Corporation | Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents |
| AU683459B2 (en) * | 1993-03-12 | 1997-11-13 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| WO1995032945A1 (en) * | 1994-06-01 | 1995-12-07 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
| AU694275B2 (en) * | 1994-09-23 | 1998-07-16 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell inflammatory conditions |
| PL322409A1 (en) * | 1995-03-24 | 1998-01-19 | Arris Pharm Corp | Reversible protease inhibitors |
| TW438591B (en) * | 1995-06-07 | 2001-06-07 | Arris Pharm Corp | Reversible cysteine protease inhibitors |
-
1997
- 1997-07-30 CN CN97196877A patent/CN1073103C/zh not_active Expired - Fee Related
- 1997-07-30 EE EEP199900036A patent/EE9900036A/xx unknown
- 1997-07-30 NZ NZ333713A patent/NZ333713A/xx unknown
- 1997-07-30 JP JP50913698A patent/JP2001509787A/ja active Pending
- 1997-07-30 AU AU39670/97A patent/AU733621B2/en not_active Ceased
- 1997-07-30 SI SI9720047A patent/SI9720047A/sl unknown
- 1997-07-30 SK SK85-99A patent/SK8599A3/sk unknown
- 1997-07-30 HU HU0003267A patent/HUP0003267A3/hu unknown
- 1997-07-30 WO PCT/US1997/013422 patent/WO1998004537A1/en not_active Application Discontinuation
- 1997-07-30 PL PL97331465A patent/PL331465A1/xx unknown
- 1997-07-30 CZ CZ99297A patent/CZ29799A3/cs unknown
- 1997-07-30 EP EP97937066A patent/EP0934293A1/en not_active Withdrawn
- 1997-07-30 CA CA002262542A patent/CA2262542A1/en not_active Abandoned
- 1997-07-30 KR KR1019997000757A patent/KR20000029679A/ko not_active Application Discontinuation
-
1999
- 1999-01-29 FI FI990171A patent/FI990171A/fi unknown
- 1999-01-29 NO NO990433A patent/NO990433L/no not_active Application Discontinuation
- 1999-02-18 LV LVP-99-27A patent/LV12291B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL331465A1 (en) | 1999-07-19 |
| CZ29799A3 (cs) | 1999-06-16 |
| CN1226892A (zh) | 1999-08-25 |
| KR20000029679A (ko) | 2000-05-25 |
| LV12291A (lv) | 1999-06-20 |
| NO990433D0 (no) | 1999-01-29 |
| EP0934293A1 (en) | 1999-08-11 |
| WO1998004537A1 (en) | 1998-02-05 |
| CA2262542A1 (en) | 1998-02-05 |
| FI990171A (fi) | 1999-03-23 |
| AU733621B2 (en) | 2001-05-17 |
| NO990433L (no) | 1999-03-25 |
| HUP0003267A3 (en) | 2002-02-28 |
| CN1073103C (zh) | 2001-10-17 |
| FI990171A0 (fi) | 1999-01-29 |
| LV12291B (en) | 2000-04-20 |
| HUP0003267A2 (hu) | 2001-06-28 |
| AU3967097A (en) | 1998-02-20 |
| EE9900036A (et) | 1999-08-16 |
| JP2001509787A (ja) | 2001-07-24 |
| NZ333713A (en) | 2000-12-22 |
| SI9720047A (sl) | 1999-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK8599A3 (en) | Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal | |
| AU721247B2 (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses | |
| CZ87097A3 (en) | Preparation for therapy and therapeutical methods for treating inflammations mediated by mast cells | |
| US20070179150A1 (en) | Nitrosated proton pump inhibitors, compositions and methods of use | |
| SK17312001A3 (sk) | Inhibítory metaloproteázy | |
| WO2000027826A1 (de) | Neue pyrimidine, deren herstellung und verwendung | |
| US7482468B2 (en) | Imidazole and benzimidazole derivatives useful as histamine H3 antagonists | |
| JP2003509417A (ja) | トリプターゼインヒビター | |
| WO2000014097A2 (de) | Neue pyranosen | |
| US7015325B2 (en) | Tryptase inhibitors | |
| DE102007010815B3 (de) | Meta-substituierte Phenylsulfonylamide sekundärer Aminosäureamide, ihre Herstellung und Verwendung als Hemmstoffe der Matriptase | |
| AU777026B2 (en) | Novel tryptase inhibitors | |
| US6815557B2 (en) | Tryptase inhibitors | |
| LT4587B (lt) | Nauji junginiai ir kompozicijos, skirti gydyti ligas, susijusias su triptazės aktyvumu | |
| MXPA99001105A (en) | Novel compounds and compositions for treating diseases associated with tryptase activity | |
| NZ506614A (en) | Compounds for treating diseases associated with tryptase activity | |
| EP1368317B1 (en) | Tryptase inhibitors | |
| WO2004060884A1 (en) | [4-(3-aminomethylphenyl) piperidin-1-yl]- [5-(2-fluorophenylethynyl)furan-2-yl]-methanone as an inhibitor of mast cell tryptase | |
| AU2002253035A1 (en) | Tryptase inhibitors | |
| LV12458B (xx) | Savienojums un farmaceitiskās kompozīcijas ar triptāzes aktivitātes izmaiņām saistītu slimību ārstēšanai | |
| JP2005535685A (ja) | トリプターゼ阻害剤としてのピロリジン誘導体 |